Aptose Biosciences Mutual Funds

Health Care & Life Sciences » Pharmaceuticals | Aptose Biosciences Inc.

Aptose Biosciences Inc. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

MFM Techinvest Technology Fund

257,061

0.75%

14,290

1.22%

03/29/2018

Marquest Small Companies Fund

9,053

0.03%

3.06%

06/29/2018

View Profile

Address	251 Consumers Road Toronto Ontario M2J 4R3 Canada
Employees	-
Website	http://aptose.com
Updated	07/08/2019
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG'806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.